bioMérieux files FDA application for rapid vaginitis diagnostic panel

FDA approves Merck's Keytruda combinations for first-line treatment of PD-L1-positive advanced triple-negative breast cancer

Ionis licenses ex-US rights to zilganersen for Alexander disease to Recordati

Dicot Pharma receives FDA clearance to start Phase 2b study of LIB-01 in US

CeleCor Therapeutics submits final section of zalunfiban (Disaggpro) New Drug Application to US FDA

Thalia Therapeutics acquires Sanmirna and raises GBP2.75m to advance AML RNA therapy

ZETA SURGICAL reports first patient treated with Zeta TMS Navigation System at HOPE Therapeutics

EU approves MAVIRET for acute hepatitis C treatment

EU approves Cenrifki for secondary progressive multiple sclerosis without relapses

Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer

Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b

FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma

Lupin announces US launch of Azilsartan Medoxomil Tablets

Akeso reports Phase II data for ligufalimab in AML

Innoviva Specialty Therapeutics signs licensing agreement with Dr. Reddy's for XACDURO international expansion